Our Divisions
Pioneering the future of medicine through specialized research, innovative technology, and global collaboration.
Division of Vaccine and Pharmacotherapies Design and Development
This division is dedicated to the innovative design and development of vaccines and therapeutic agents to combat infectious diseases, with a particular focus on conditions affecting populations across Africa. Leveraging advanced scientific approaches and strategic partnerships with national and global health organisations, the division works to translate cutting-edge research into practical interventions that strengthen disease prevention, improve treatment outcomes, and advance public health both within the region and globally.
- Rational Vaccine Design: Immunoinformatics, computational biology & vaccine targets
- Pharmacotherapy Development: Discovery of novel therapeutic compounds & biologics
- Preclinical Research: In-silico modelling, antigen screening & laboratory validation
- Disease Surveillance Support: Genomics & bioinformatics for pathogen tracking
- Capacity Building: Training students & early-career scientists
- Collaborative Research: Partnerships with global health organisations
- Policy and Public Health Translation: Evidence-based recommendations
- Community Engagement: Disease awareness & health literacy

Division of Animal and Experimental Studies
This division serves as the central scientific resource for biomedical research and translational studies. It is dedicated to the ethical utilization, rigorous care, and in-depth study of laboratory animal models, ensuring reliable and reproducible experimental outcomes in alignment with the highest welfare standards.
- Advancing Biomedical Research and Modeling: Preclinical studies & safety validation
- Upholding Ethical Standards: Adherence to the 3 Rs (Replacement, Reduction, Refinement)
- Mastery of Animal Husbandry and Reproductive Physiology: High-quality animal colonies

Division of Diagnostic Assay Development and Medical AI
Focuses on the research, design, and implementation of advanced diagnostic technologies and AI-driven medical solutions. This division integrates cutting-edge methodologies, such as molecular diagnostics, biosensors, and imaging technologies, with artificial intelligence and machine learning to enhance disease detection, prediction, and patient care.
- Research & Development (R&D): Innovating diagnostic assays & AI tools
- Clinical Validation & Testing: Evaluating performance in real-world settings
- Data Analytics & Integration: Predictive analysis & decision support
- Regulatory Compliance & Quality Assurance: Meeting industry standards
- Collaborations & Partnerships: Working with hospitals & biotech firms
- Custom Diagnostic Assay Development: Tailored biomarkers
- Pre-clinical and Clinical Trial Support: AI & diagnostic solutions
- Consulting & Training: Expertise in AI applications in healthcare

Division of Genome and Molecular Sciences
Dedicated to advancing research in genomics, molecular biology, and bioinformatics. Its primary focus is on studying the genetic foundations of diseases, applying genome-editing technologies, and exploring molecular pathways to drive innovative solutions in healthcare.
- Microbiological Assay Services: AST, Pathogen Identification, Environmental Testing
- Molecular Biology Assay Services: Nucleic Acid Extraction, PCR, Gel Electrophoresis, Genomic Sequencing, ELISA
- Genomic Data Analysis Services: 16S rRNA Analysis, Whole Genome Sequencing Analysis, Metagenomics, Phylogenomics, Evolutionary Analysis
- Training and Capacity Building: Structured training & professional development
